Female infertility refers to infertility in women. It affects an estimated 48 million women,with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia.
This report aims to provide a comprehensive presentation of the global market for Female Infertility Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Infertility Drugs. This report contains market size and forecasts of Female Infertility Drugs in global, including the following market information:
Global Female Infertility Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Female Infertility Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The adverse effects and high cost of non-therapeutics will also boost the popularity of female infertility drugs. Various ART procedures, including IVF, IUI, and ICSI are available as alternatives to medications for the treatment of female infertility.
We surveyed the Female Infertility Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Female Infertility Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Female Infertility Drugs Market Segment Percentages, by Type, 2022 (%)
Parenteral
Oral
Others
Global Female Infertility Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Female Infertility Drugs Market Segment Percentages, by Application, 2022 (%)
Ovarian Hyperstimulation Syndrome
Multiple-gestation Pregnancies
Multiple-birth Infants
Premature Labor
Low Birth Weight
Risk of Cesarean Delivery
Global Female Infertility Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Female Infertility Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Female Infertility Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Female Infertility Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Female Infertility Drugs, market overview.
Chapter 2: Global Female Infertility Drugs market size in revenue.
Chapter 3: Detailed analysis of Female Infertility Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Female Infertility Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Female Infertility Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Female Infertility Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Female Infertility Drugs Overall Market Size
2.1 Global Female Infertility Drugs Market Size: 2022 VS 2030
2.2 Global Female Infertility Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Female Infertility Drugs Players in Global Market
3.2 Top Global Female Infertility Drugs Companies Ranked by Revenue
3.3 Global Female Infertility Drugs Revenue by Companies
3.4 Top 3 and Top 5 Female Infertility Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Female Infertility Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Female Infertility Drugs Players in Global Market
3.6.1 List of Global Tier 1 Female Infertility Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Female Infertility Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Female Infertility Drugs Market Size Markets, 2022 & 2030
4.1.2 Parenteral
4.1.3 Oral
4.1.4 Others
4.2 By Type - Global Female Infertility Drugs Revenue & Forecasts
4.2.1 By Type - Global Female Infertility Drugs Revenue, 2018-2023
4.2.2 By Type - Global Female Infertility Drugs Revenue, 2024-2030
4.2.3 By Type - Global Female Infertility Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Female Infertility Drugs Market Size, 2022 & 2030
5.1.2 Ovarian Hyperstimulation Syndrome
5.1.3 Multiple-gestation Pregnancies
5.1.4 Multiple-birth Infants
5.1.5 Premature Labor
5.1.6 Low Birth Weight
5.1.7 Risk of Cesarean Delivery
5.2 By Application - Global Female Infertility Drugs Revenue & Forecasts
5.2.1 By Application - Global Female Infertility Drugs Revenue, 2018-2023
5.2.2 By Application - Global Female Infertility Drugs Revenue, 2024-2030
5.2.3 By Application - Global Female Infertility Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Female Infertility Drugs Market Size, 2022 & 2030
6.2 By Region - Global Female Infertility Drugs Revenue & Forecasts
6.2.1 By Region - Global Female Infertility Drugs Revenue, 2018-2023
6.2.2 By Region - Global Female Infertility Drugs Revenue, 2024-2030
6.2.3 By Region - Global Female Infertility Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Female Infertility Drugs Revenue, 2018-2030
6.3.2 US Female Infertility Drugs Market Size, 2018-2030
6.3.3 Canada Female Infertility Drugs Market Size, 2018-2030
6.3.4 Mexico Female Infertility Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Female Infertility Drugs Revenue, 2018-2030
6.4.2 Germany Female Infertility Drugs Market Size, 2018-2030
6.4.3 France Female Infertility Drugs Market Size, 2018-2030
6.4.4 U.K. Female Infertility Drugs Market Size, 2018-2030
6.4.5 Italy Female Infertility Drugs Market Size, 2018-2030
6.4.6 Russia Female Infertility Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Female Infertility Drugs Market Size, 2018-2030
6.4.8 Benelux Female Infertility Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Female Infertility Drugs Revenue, 2018-2030
6.5.2 China Female Infertility Drugs Market Size, 2018-2030
6.5.3 Japan Female Infertility Drugs Market Size, 2018-2030
6.5.4 South Korea Female Infertility Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Female Infertility Drugs Market Size, 2018-2030
6.5.6 India Female Infertility Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Female Infertility Drugs Revenue, 2018-2030
6.6.2 Brazil Female Infertility Drugs Market Size, 2018-2030
6.6.3 Argentina Female Infertility Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Female Infertility Drugs Revenue, 2018-2030
6.7.2 Turkey Female Infertility Drugs Market Size, 2018-2030
6.7.3 Israel Female Infertility Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Female Infertility Drugs Market Size, 2018-2030
6.7.5 UAE Female Infertility Drugs Market Size, 2018-2030
7 Female Infertility Drugs Companies Profiles
7.1 Allergan Plc
7.1.1 Allergan Plc Company Summary
7.1.2 Allergan Plc Business Overview
7.1.3 Allergan Plc Female Infertility Drugs Major Product Offerings
7.1.4 Allergan Plc Female Infertility Drugs Revenue in Global Market (2018-2023)
7.1.5 Allergan Plc Key News & Latest Developments
7.2 Ferring BV
7.2.1 Ferring BV Company Summary
7.2.2 Ferring BV Business Overview
7.2.3 Ferring BV Female Infertility Drugs Major Product Offerings
7.2.4 Ferring BV Female Infertility Drugs Revenue in Global Market (2018-2023)
7.2.5 Ferring BV Key News & Latest Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Company Summary
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Female Infertility Drugs Major Product Offerings
7.3.4 Merck KGaA Female Infertility Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck KGaA Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Female Infertility Drugs Major Product Offerings
7.4.4 Novartis AG Female Infertility Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Female Infertility Drugs Major Product Offerings
7.5.4 Sanofi Female Infertility Drugs Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Female Infertility Drugs Market Opportunities & Trends in Global Market
Table 2. Female Infertility Drugs Market Drivers in Global Market
Table 3. Female Infertility Drugs Market Restraints in Global Market
Table 4. Key Players of Female Infertility Drugs in Global Market
Table 5. Top Female Infertility Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Female Infertility Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Female Infertility Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Female Infertility Drugs Product Type
Table 9. List of Global Tier 1 Female Infertility Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Female Infertility Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Female Infertility Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Female Infertility Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Female Infertility Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Female Infertility Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Female Infertility Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Female Infertility Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Female Infertility Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Female Infertility Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Female Infertility Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Female Infertility Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Female Infertility Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Female Infertility Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Female Infertility Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Female Infertility Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Female Infertility Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Female Infertility Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Female Infertility Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Female Infertility Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Female Infertility Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Allergan Plc Company Summary
Table 31. Allergan Plc Female Infertility Drugs Product Offerings
Table 32. Allergan Plc Female Infertility Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Allergan Plc Key News & Latest Developments
Table 34. Ferring BV Company Summary
Table 35. Ferring BV Female Infertility Drugs Product Offerings
Table 36. Ferring BV Female Infertility Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Ferring BV Key News & Latest Developments
Table 38. Merck KGaA Company Summary
Table 39. Merck KGaA Female Infertility Drugs Product Offerings
Table 40. Merck KGaA Female Infertility Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck KGaA Key News & Latest Developments
Table 42. Novartis AG Company Summary
Table 43. Novartis AG Female Infertility Drugs Product Offerings
Table 44. Novartis AG Female Infertility Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis AG Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Female Infertility Drugs Product Offerings
Table 48. Sanofi Female Infertility Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Female Infertility Drugs Segment by Type in 2022
Figure 2. Female Infertility Drugs Segment by Application in 2022
Figure 3. Global Female Infertility Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Female Infertility Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Female Infertility Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Female Infertility Drugs Revenue in 2022
Figure 8. By Type - Global Female Infertility Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Female Infertility Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Female Infertility Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Female Infertility Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Female Infertility Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Female Infertility Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Female Infertility Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Female Infertility Drugs Revenue Market Share, 2018-2030
Figure 16. US Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Female Infertility Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Female Infertility Drugs Revenue Market Share, 2018-2030
Figure 28. China Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Female Infertility Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Female Infertility Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Female Infertility Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Allergan Plc Female Infertility Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Ferring BV Female Infertility Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck KGaA Female Infertility Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis AG Female Infertility Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Female Infertility Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
